Zhang Lidan, Huang Huimin, Cheng Yucai, Xu Lingling, Huang Xueqiong, Pei Yuxin, Tang Wen, Qin Zhaoyuan
Pediatric ICU, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, Guangdong, China (Zhang LD, Huang HM, Cheng YC, Xu LL, Huang XQ, Pei YX, Tang W); Department of Pediatrics, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, Guangdong, China (Qin ZY). Corresponding author: Qin Zhaoyuan, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Jan;30(1):51-56. doi: 10.3760/cma.j.issn.2095-4352.2018.01.010.
To assess the performance of pediatric clinical illness score (PCIS), pediatric risk of mortality score III (PRISM III), pediatric logistic organ dysfunction score 2 (PELOD-2), and pediatric multiple organ dysfunction score (P-MODS) in predicting mortality in critically ill pediatric patients.
The data of critically ill pediatric patients admitted to Pediatric Intensive Care Unit (PICU) of First Affiliated Hospital of Sun Yat-Sen University from August 2012 to May 2017 were retrospectively analyzed. The gender, age, basic diseases, the length of PICU stay were collected. The children were divided into survival group and non-survival group according to the clinical outcome during hospitalization. The variables of PCIS, PRISM III, PELOD-2, and P-MODS were collected and scored. Receiver operating characteristic (ROC) curve was plotted, the efficiency of PCIS, PRISM III, PELOD-2, and P-MODS for predicting death were evaluated by the area under ROC curve (AUC). Hosmer-Lemeshow goodness of fit test was used to evaluate the fitting degree of each scoring system to predict the mortality and the actual mortality.
Of 461 critically ill children, 35 children were excluded because of serious data loss, hospital stay not exceeding 24 hours, and death within 8 hours after admission. Finally, a total of 426 pediatric patients were enrolled in this study. 355 pediatric patients were survived, while 71 were not survived during hospitalization, with the mortality of 16.7%. There was no significant difference in gender, age, underlying diseases or length of PICU stay between the two groups. PCIS score in non-survival group was significantly lower than that of survival group [80 (76, 88) vs. 86 (80, 92)], and PRISM III, PELOD-2 and P-MODS scores were significantly increased [PRISM III: 16 (13, 22) vs. 12 (10, 15), PELOD-2: 6 (5, 9) vs. 4 (2, 5), P-MODS: 6 (4, 9) vs. 3 (2, 6), all P < 0.01]. ROC curve analysis showed that the AUCs of PCIS, PRISM III, PELOD-2, and P-MODS for predicting death of critical ill children were 0.649, 0.731, 0.773, and 0.747, respectively. Hosmer-Lemeshow test showed that PCIS predicted the mortality and the actual mortality in the best fitting effect (χ = 7.573, P = 0.476), followed by PELOD-2 and P-MODS (χ = 9.551, P = 0.145; χ = 10.343, P = 0.111), while PRISM III had poor fitting effect (χ = 43.549, P < 0.001).
PRISM III, PELOD-2 and P-MODS can discriminate between survivors and moribund patients well, and assessing the condition of critically ill pediatric patients with relatively accuracy. PCIS was the best fitting effect in predicting mortality and actual mortality, followed by PELOD-2 and P-MODS, while PRISM III had poor fitting effect.
评估儿科临床疾病评分(PCIS)、儿科死亡风险评分Ⅲ(PRISMⅢ)、儿科逻辑器官功能障碍评分2(PELOD - 2)及儿科多器官功能障碍评分(P - MODS)对危重症儿科患者死亡率的预测性能。
回顾性分析2012年8月至2017年5月中山大学附属第一医院儿科重症监护病房(PICU)收治的危重症儿科患者的数据。收集患者的性别、年龄、基础疾病、PICU住院时间。根据住院期间的临床结局将患儿分为存活组和非存活组。收集并计算PCIS、PRISMⅢ、PELOD - 2及P - MODS的变量得分。绘制受试者工作特征(ROC)曲线,通过ROC曲线下面积(AUC)评估PCIS、PRISMⅢ、PELOD - 2及P - MODS预测死亡的效能。采用Hosmer - Lemeshow拟合优度检验评估各评分系统对预测死亡率与实际死亡率的拟合程度。
461例危重症患儿中,35例因数据严重缺失、住院时间不足24小时及入院后8小时内死亡被排除。最终,本研究共纳入426例儿科患者。355例儿科患者存活,71例住院期间死亡,死亡率为16.7%。两组在性别、年龄、基础疾病或PICU住院时间方面无显著差异。非存活组的PCIS评分显著低于存活组[80(76,88)对86(80,92)],而PRISMⅢ、PELOD - 2及P - MODS评分显著升高[PRISMⅢ:16(13,22)对12(10,15),PELOD - 2:6(5,9)对4(2,5),P - MODS:6(4,9)对3(2,6),均P<0.01]。ROC曲线分析显示,PCIS、PRISMⅢ、PELOD - 2及P - MODS预测危重症患儿死亡的AUC分别为0.649、0.731、0.773及0.747。Hosmer - Lemeshow检验显示,PCIS对死亡率与实际死亡率的拟合效果最佳(χ² = 7.573,P = 0.476),其次是PELOD - 2和P - MODS(χ² = 9.551,P = 0.145;χ² = 10.343,P = 0.111),而PRISMⅢ的拟合效果较差(χ² = 43.549,P<0.001)。
PRISMⅢ、PELOD - 2及P - MODS能较好地区分存活者和濒死患者,并相对准确地评估危重症儿科患者的病情。PCIS在预测死亡率与实际死亡率方面的拟合效果最佳,其次是PELOD - 2和P - MODS,而PRISMⅢ的拟合效果较差。